Tenon Medical closes $4.3M private placement of senior convertible notes

Tenon Medical, Inc.

Aggregate gross proceeds of $4.3M from senior convertible promissory notes with 20% original issue discount.
Notes mature September 11, 2026 (extendable to December 11, 2026); conversion at 80% of 3-day VWAP after six months.
Net proceeds for commercial expansion, product development, clinical studies, and working capital.
WallachBeth Capital acted as placement agent; notes unregistered under Regulation D.
If maturity extended, principal increases 5%; prepayment at 102.5% plus 15% of net proceeds from future financings.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Tenon Medical, Inc. entered into Purchase Agreements with certain accredited investors valued at $4.3 million (effective 2026-03-11).

Action: entry
Agreement: equity purchase
Counterparty: certain accredited investors
Value: $4.3 million
Effective: 2026-03-11

Exact text from the filing

On March 11, 2026, Tenon Medical, Inc., a Delaware corporation (the “Company”), entered into securities purchase agreements (the “Purchase Agreements”) with certain accredited investors (the “Purchasers”) pursuant to which the Company agreed to issue and sell in a private placement an aggregate principal amount of $4.3 million 20% Original Issue Discount Senior Convertible Promissory Notes (the “Notes”) for aggregate gross proceeds of approximately $4.3 million before deducting fees and expenses of the placement agent.

View on SEC.gov

312 material agreements filed in the last 30 days. Browse all material agreements →

Tenon Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-028569

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.